New study shows species-specific ‘shedding’ could distort efficacy of cancer drugs targeting TIGIT
Peer-Reviewed Publication
Updates every hour. Last Updated: 6-Dec-2025 19:11 ET (7-Dec-2025 00:11 GMT/UTC)
Anti-TIGIT immunotherapy drugs behave differently in macaques and humans. The findings may explain why immunotherapy anti-TIGIT antibodies have failed in Phase III trials.
Half of people who die by suicide have no diagnosed psychiatric risk factors, such as depression. It was unclear whether this population was depressed and undiagnosed, or simply not depressed. Genetic research shows that this population is less likely to have genetic risk factors for depression, suggesting that what puts them at risk is meaningfully different.